Valneva SE (VALN) Long-Term Deferred Tax (2020 - 2026)

Valneva SE (VALN) posted quarterly Long-Term Deferred Tax of $8.8 million for Q1 2026, down 2.27% year-on-year from $9.0 million in Q1 2025, and down 6.81% on a QoQ basis from $9.5 million in Q4 2025.

Valneva SE (VALN) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Long-Term Deferred Tax for 7 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Long-Term Deferred Tax fell 2.27% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 2.27% YoY) and the FY2025 annual result came in at $9.5 million, down 13.32% from the prior year.
  • Long-Term Deferred Tax retreated to $8.8 million in Q1 2026 per VALN's latest filing, from $9.5 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for VALN reached as high as $236.5 million in Q4 2023 and fell as low as $3.0 million in Q2 2022.
  • A 5-year average of $21.6 million and a median of $8.8 million in 2026 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax soared 3587.39% — and 2024, when it slumped 95.38%.
  • Year by year, Long-Term Deferred Tax stood at $6.4 million in 2022, then surged by 3587.39% to $236.5 million in 2023, then sank by 95.38% to $10.9 million in 2024, then retreated by 13.32% to $9.5 million in 2025, then fell by 6.81% to $8.8 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $8.8 million, $9.5 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.83 Mn
Dec 31, 2025 9.47 Mn
Sep 30, 2025 8.35 Mn
Jun 30, 2025 9.11 Mn
Mar 31, 2025 9.03 Mn
Dec 31, 2024 10.93 Mn
Sep 30, 2024 13.28 Mn
Jun 30, 2024 8.72 Mn
Mar 31, 2024 7.97 Mn
Dec 31, 2023 236.53 Mn
Sep 30, 2023 10.46 Mn
Jun 30, 2023 11.30 Mn
Mar 31, 2023 6.99 Mn
Dec 31, 2022 6.41 Mn
Sep 30, 2022 3.35 Mn
Jun 30, 2022 3.05 Mn
Mar 31, 2022 3.76 Mn
Dec 31, 2021 4.08 Mn
Dec 31, 2020 6.34 Mn